Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Condensed Interim Consolidated Statements of Cash Flows (Unaudited)

v3.21.2
Condensed Interim Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Operating    
Net loss $ (24,289) $ (3,552)
Non-cash items    
Depreciation and amortization 403 89
Interest expense on lease liabilities 53
Stock-based compensation expense 3,620 721
(Gain) loss on change in fair value of warrants (3,560) 4,794
Non-cash issue costs 764
Non-cash settlement included in payables 2,090
Accrued interest on Note payable 115 187
Changes in non-cash working capital balances    
Prepaid expenses and deposits (223) (330)
Accounts payable and accrued liabilities (441) (5,604)
Cash used in operating activities (24,322) (841)
Financing    
Exercise of Derivative warrants 8,000
January 2021 Equity Offering, net of issuance costs 10,375
February 2021 Equity Offering, net of issuance costs 21,093
Exercise of Equity warrants 1,985
Exercise of stock options 14
Proceeds from issuance of common shares 2,709 23,490
Note payable 135 1,500
Repayment of lease liabilities (180) (34)
Cash provided by financing activities 44,131 24,956
Investing    
Purchase of property, plant and equipment (333) (79)
Purchase of patents (268) (175)
Cash used in investing activities (601) (254)
Increase in cash 19,208 23,861
Cash, beginning of the period 25,469 814
Cash, end of the period $ 44,677 $ 24,675